Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CRITICAL INNOVATIONS LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-03-08 to 2025-07-07
Current total value of award: $1100000
Description: DHA SBIR PHASE II -H2-0717 TOPIC DHA213-009 TITLE:RX- SHOOTER WEARABLE WOUND INFECTION TREATMENT DEVICE CRITICAL INNOVATIONS. MEDICAL R & D CONTRACT